An Illinois HMO enrollee suffered a serious nerve disorder. Her primary care physician and specialists sought authorization for surgery by an out-of-network surgeon. The HMO denied authorization, concluding that the proposed treatment was not medically necessary under the plan and could be addressed in-network. Illinois's HMO Act provided that when an HMO denies treatment as not medically necessary, the enrollee may obtain an independent medical review by a board-certified physician in the relevant specialty, and if the independent reviewer finds the treatment medically necessary, the HMO must cover it. The enrollee invoked the Illinois process and obtained a favorable independent determination, but the HMO still refused payment. She sued in Illinois state court to compel coverage and reimbursement in accordance with the independent review. The HMO argued ERISA preempted the Illinois requirement because it related to an employee benefit plan and conflicted with ERISA's exclusive remedies. Illinois courts rejected the preemption challenge and ordered the HMO to comply. The Supreme Court granted certiorari to resolve whether the Illinois independent-review mandate is preempted by ERISA or saved as a law regulating insurance, and whether it is compatible with ERISA's civil enforcement scheme.
Does ERISA preempt an Illinois statute requiring HMOs to provide and abide by an independent medical-necessity review of denied treatments, or is the statute a law that regulates insurance saved from preemption and consistent with ERISA's exclusive civil enforcement remedial structure?
Under ERISA § 514(a), state laws that "relate to" employee benefit plans are preempted. However, § 514(b)(2)(A) (the saving clause) preserves from preemption state laws that "regulate insurance," while § 514(b)(2)(B) (the deemer clause) prevents states from deeming an employee benefit plan itself to be an insurer. To determine whether a law "regulates insurance," courts apply a common-sense view, informed by the McCarran-Ferguson factors: whether the law is specifically directed at entities engaged in insurance; whether it substantially affects the risk-pooling arrangement between insurer and insured or is integral to the policy relationship; and whether it is limited to insurers. Even if saved, a state law cannot provide an alternative or supplemental remedial scheme that conflicts with ERISA's exclusive civil enforcement provision, § 502(a) (Pilot Life). But state laws may impose insurance rules that affect the content, processing, or interpretation of insured ERISA plans so long as the remedy remains through § 502(a)(1)(B) to recover benefits due under the plan (Metropolitan Life; UNUM v. Ward).
The Illinois HMO Act's independent medical-necessity review requirement is a law regulating insurance saved from ERISA preemption. It does not conflict with ERISA's exclusive civil enforcement scheme because it does not create a separate cause of action or additional remedies; it simply supplies an insurance rule and review mechanism that govern benefit determinations enforceable under ERISA § 502(a)(1)(B).
The Court began with ERISA's structure: a broad preemption clause is tempered by the saving clause preserving state insurance regulation, and the deemer clause shielding self-funded ERISA plans from being treated as insurers. Applying the saving clause analysis, the Illinois provision is specifically directed at HMOs—entities engaged in the business of insurance—by prescribing the terms and procedures under which benefits must be provided when medical necessity is disputed. It is integral to the policy relationship by dictating how and when coverage is owed, and it affects the risk-pooling arrangement by constraining the insurer's discretion to withhold benefits on medical-necessity grounds once an independent specialist finds the service necessary. Thus, under a common-sense view and the McCarran-Ferguson factors, the law regulates insurance and is saved from preemption. The deemer clause poses no barrier because Illinois regulates HMOs as insurers; it does not attempt to treat self-funded ERISA plans as insurers, and the statute does not apply to such self-funded arrangements. Turning to ERISA's remedial exclusivity, the Court distinguished preempted state laws that create alternate causes of action or extra-contractual damages (e.g., bad-faith or punitive damages) from state insurance rules that shape the content or procedures of insured plans but leave enforcement to § 502(a)(1)(B). The Illinois law does not authorize damages beyond plan benefits, nor does it create a freestanding tort or contract action. Rather, it requires an insurer to submit medical-necessity disputes to an independent physician and to honor that determination; the participant still enforces her right to benefits in court through ERISA's remedial channel. In this respect, the statute resembles the notice-prejudice rule in UNUM v. Ward: a state insurance mandate that supplies a binding rule of decision within the plan context, not a competing remedy. The Court rejected the HMO's argument that independent review functioned as impermissible arbitration replacing judicial review. The external reviewer's role is to supply an expert medical-necessity determination that, as a matter of state insurance law, becomes part of the governing terms for coverage. Courts remain available to enforce benefits and to review compliance under § 502(a)(1)(B). Finally, the Court emphasized that ERISA does not demand ERISA-wide uniformity in the substance of insured benefits; states may mandate benefit content and claims procedures for insurers, even if that produces variation among states, so long as self-funded plans remain beyond those mandates under the deemer clause.
Rush Prudential clarifies that state external review and similar patient-protection statutes directed at insurers can coexist with ERISA. It anchors two core lessons for students: (1) the saving clause preserves robust state regulation of insured ERISA plans when the law truly regulates insurance, and (2) ERISA's exclusive remedies preempt alternative damages schemes but do not bar state rules that shape plan terms or claim procedures so long as enforcement remains under § 502(a)(1)(B). The case is frequently paired with Metropolitan Life, Pilot Life, and UNUM v. Ward to map the preemption landscape and is a foundational decision for understanding modern health-insurance regulation and managed-care oversight.
Rush Prudential HMO v. Moran marks a pivotal point in ERISA preemption doctrine, confirming space for state-level patient protections within the federal framework. The Court's saving-clause analysis preserves state authority to regulate insurers' benefit determinations and claim procedures while respecting ERISA's uniform remedial scheme.